Docebo Inc. logo

Docebo Inc. (DCBO)

Market Closed
17 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
21. 76
-0.63
-2.81%
$
619.34M Market Cap
563.91 P/E Ratio
0% Div Yield
80,019 Volume
0.9 Eps
$ 22.39
Previous Close
Day Range
21.73 22.8
Year Range
20.2 48.3
Want to track DCBO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 71 days
Docebo Inc. (DCBO) Q3 2024 Earnings Call Transcript

Docebo Inc. (DCBO) Q3 2024 Earnings Call Transcript

Docebo Inc. (NASDAQ:DCBO ) Q3 2024 Earnings Conference Call November 8, 2024 8:00 AM ET Company Participants Mike McCarthy - VP, IR Alessio Artuffo - CEO Sukaran Mehta - CFO Conference Call Participants Ryan MacDonald - Needham Suthan Sukumar - Stifel Robert Young - Canaccord Genuity Josh Baer - Morgan Stanley Richard Tse - National Bank Financial Stephanie Price - CIBC Daniel Chan - TD Cowen Kevin Krishnaratne - Scotiabank Martin Toner - ATB Capital Markets Kiran Sritharan - Eight Capital Operator Good morning, everyone, and welcome to the Docebo Third Quarter 2024 Earnings Call. All participants are currently in listen-only mode.

Seekingalpha | 1 year ago
Docebo Inc. (DCBO) Q3 Earnings and Revenues Top Estimates

Docebo Inc. (DCBO) Q3 Earnings and Revenues Top Estimates

Docebo Inc. (DCBO) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.15 per share a year ago.

Zacks | 1 year ago
Docebo Improves Operating Leverage And Readies US Government Push (Upgrade)

Docebo Improves Operating Leverage And Readies US Government Push (Upgrade)

Docebo Inc. is successfully broadening its customer base and moving upmarket. The global e-learning market is projected to grow at a CAGR of 18.6% from 2024 to 2030, driven by cost efficiencies and hybrid work environments. Docebo's financials show rising revenue, stable gross profit margins, and improved operating income due to automation, with no debt and strong free cash flow.

Seekingalpha | 1 year ago
Docebo Inc. (DCBO) Q2 Earnings and Revenues Beat Estimates

Docebo Inc. (DCBO) Q2 Earnings and Revenues Beat Estimates

Docebo Inc. (DCBO) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.14 per share a year ago.

Zacks | 1 year ago
Docebo Inc. (DCBO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Docebo Inc. (DCBO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Docebo (DCBO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
M&A Watch: 3 Canadian Companies That Should Be on American Firms' Buy Lists

M&A Watch: 3 Canadian Companies That Should Be on American Firms' Buy Lists

On July 11, private equity firm Platinum Equity Advisors announced that it would acquire Héroux-Devtek (OTCMKTS: HERXF ), a Quebec-based aerospace firm. The $1.35 billion deal is one of the many Canadian acquisition targets that are or should be on American firms' buy lists.

Investorplace | 1 year ago
2 No-Brainer Stocks to Buy With $50 Right Now

2 No-Brainer Stocks to Buy With $50 Right Now

Warren Buffett believes investors should buy understandable, reasonably priced stocks whose earnings should grow substantially in the future. UiPath is the market leader in robotic process automation, one of the fastest-growing software markets, and the company has a compelling pipeline of AI products.

Fool | 1 year ago
Is Docebo (DCBO) a Buy as Wall Street Analysts Look Optimistic?

Is Docebo (DCBO) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks | 1 year ago